A defect in inducible β-galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse

Immunology

Volumn 88, Issue 4, 1996, Pages 604-610

  Yamamoto, N ^a   Naraparaju, V R ^a  

^a ALBERT EINSTEIN CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; LYSOPHOSPHATIDYLCHOLINE; MACROPHAGE ACTIVATING FACTOR; VITAMIN D BINDING PROTEIN;

ALBERS SCHOENBERG DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; MACROPHAGE; MOUSE; MUTANT; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL;

EID: 0030056126     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-684.x     Document Type: Article

References (36)

1. HUFFER W.E. (1988) Biology of disease: morphology and biochemistry by vitamin D. parathyroid hormone, and other substances. Lab Invest 59, 418.
2. MARKS S.C., JR (1984) Congenital osteopetrotic mutations as probes of the origin, structure and function of osteoclasts. Clin Orthop 189, 239.
3. MARKS S.C., JR (1989) Osteoclast biology: Lessons from mammalian mutations. Am J Med Genet 34, 43.
4. ORCHARD P.J., DAHL N., AUKERMAN S.L., BLAZAR B.R. & KEY L.L., JR (1992) Circulating macrophage colony-stimulating factor is not reduced in malignant osteopetrosis. Exp Hematol 20, 103.
5. REEVES J.D., AUGUST C.S., HUMBERT J.R. & WESTON W.L. (1979) Host defense in infantile osteopetrosis. Pediatrics 64, 202.
6. SORELL M., KAPOOR N., KIRKPATRIK D. et al. (1981) Marrow transplantation for juvenile osteopetrosis. Am J Med 70, 1280.
7. KEY L.L., RIES W.L., VAN CAMP T.M., PITZER B.L. & SHEPARD A. (1990) Administration of Interferon gamma to osteopetrotic mice stimulates bone resorption. J Bone and Min Res 5 (Suppl. 2): 102A.
8. THESINGH C.W. & SCHERFT J.P. (1985) Fusion disability of embryonic osteoclast precursor cells and macrophages in the microphthalmic osteopetrotic mouse. Bone 6, 43.
9. MARKS S.C., JR & LANE P.W. (1976) Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J Hered 67, 11.
10. YAMAMOTO N., LINDSAY D.D., NARAPARAJU V.R., IRELAND R.A. & POPOFF S.N. (1994) A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats. J Immunol 152, 5100.
11. MARKS S.C., JR. WOJTOWICZ A., SZPERI. M. et al. (1992) Administration of colony stimulating factor-1 corrects some macrophages, dental, skeletal defects in an osteopetrotic mutation (Toothless, tl) in the rat. Bone 13, 89.
12. TEITELBAUM S.L. & KAHN A.J. (1980) Mononuclear phagocytes, osteoclasts and bone resorption. Min Electrolyte Metab 3, 2.
13. TEITELBAUM S.L., STEWART C.C. & KAHN A.J. (1979) Rodent peritoneal macrophages as bone resorbing cells. Calcif Tissue Int 27, 255.
14. KAHN A.J., STEWART C.C. & TEITELBAUM S.L. (1978) Contact-mediated hone resorption by human monocytes in vitro. Science 199, 988.
15. 3 binding protein (Group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages. J Immunol 147, 273.
16. HOMMA S., YAMAMOTO M. & YAMAMOTO N. (1993) Vitamin D binding protein (Group-specific component, Gc) is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine. Immunol Cell Biol 71, 249.
17. 3 binding protein (group-specific component, Gc) is a precursor for the macrophage activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc Natl Acad Sci USA 88, 8539.
18. 3 binding protein (Group-specific component) to a macrophage activating factor by the stepwise action of β-galactosidase of B cells and sialidase of T cells. J Immunol 151, 2794.
19. NARAPARAJU V.R. & YAMAMOTO N. (1994) Roles of β-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages. Immunology Lett 43, 143.
20. YAMAMOTO N. & NARAPARAJU V.R. (1996) Inflammation-primed macrophage activation in rats. Cell Immunol 170, 161.
21. YAMAMOTO N. & NARAPARAJU V.R. (1996) A Defect in β-galactosidase of B lymphocytes in the osteopetrotic (op/op) mouse. Immunol Lett 50, 35.
22. COPPENHAVER D.H., SOLLENNE N.P. & BOWMAN B.H. (1983) Post-translational heterogeneity of the human vitamin D-binding protein (group-specific component). Arch Biochem Biophys 226, 218.
23. VIAU M., CONSTANS J., DEBRAY H. & MONTREUIL J. (1983) Isolation and characterization of the o-glycan chain of the human vitamin D-binding protein. Biochem Biophys Res Comm 117, 324.
24. 3-sepharose chromatography. Anal Biochem 157, 262.
25. NGWENYA B.Z. & YAMAMOTO N. (1990) Contribution of lysophosphatidylcholine-treated non-adherent cells to mechanism of macrophage activation. Proc Soc Exp Biol Med 193, 118.
26. HOMMA S. & YAMAMOTO N. (1990) Activation process of macrophages after in vitro treatment of mouse lymphocytes with dodecylglycerol. Clin Exp Immunol 79, 307.
27. 3-binding protein and albumin. Inf Imm 61, 5388.
28. YAMAMOTO N., WILLETT N.P. & LINDSAY D.D. (1994) Participation of serum proteins in the inflammation-primed activation of macrophages. Inflammation 18, 311.
29. COOKE N. (1986) Rat vitamin D binding protein. Determination of the full-length primary structure from cloned cDNA. J Biol Chem 261, 3441.
30. YOSHIDA H., HAYASHI S., KUNISADA T. et al. (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature (London) 345, 442.
31. WIKTOR-JEDRZEJCZAK W., BARTOCCI A., FERRANTE A.W., JR et al. (1990) Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 87, 4828.
32. KODAMA H., YAMASAKI A., NOSE N. et al. (1991) Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med 173, 269.
33. WIKTOR-JEDRZEJCZAK W., URBANOWSKA E., AUKERMAN S.L. et al. (1991) Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. Exp Hematol 19, 1049.
34. YUI M.A., BRISSETTE W.H., BRENNAN D.C., WUTHRICH R.P. & RUBIN-KELLY, V.E. (1991) Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice. Am J Path 139, 255.
35. ORCHARD P.J., DAHL N., AUKERMAN S.L., BLAZAR B.R. & KEY L.L., JR (1992) Circulating macrophage colony-stimulating factor is not reduced in malignant osteopetrosis. Exp Hematol 20, 103.
36. YAMAMOTO N., NARAPARARAJU V.R. & ORCHARD P.J. (1996) Defective lymphocyte glycosidases in the macrophage activation cascade of juvenile osteopetrosis. Blood 88, in press.